Saliva gene promoter hypermethylation as a biomarker in oral cancer

Ó Rapado-González, JL López-Cedrún… - Journal of Clinical …, 2021 - mdpi.com
Oral carcinogenesis is a multistep process characterized by a summation of multiple genetic
and epigenetic alterations in key regulatory genes. The silencing of genes by aberrant …

Enhancing the cancer metastasis diagnosis: Ultrasensitive nano sensors exploiting Cancer stem cell associated DNA methylation as a liquid biopsy marker

S Ganesh, S Premachandran… - Sensors and Actuators B …, 2024 - Elsevier
Cancer metastasis presents a significant clinical challenge due to its impact on patient
survival rates. Early detection of metastasis is pivotal for effective intervention and improved …

Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma

S Temraz, R Nasr, D Mukherji, F Kreidieh… - Expert Review of …, 2022 - Taylor & Francis
Introduction The diagnosis of hepatocellular carcinoma (HCC) is made at a relatively
advanced stage resulting in poor prognosis. Alpha-fetoprotein and liver ultrasound have …

[HTML][HTML] Challenges in promoter methylation analysis in the new era of translational oncology: a focus on liquid biopsy

C Mio, G Damante - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2022 - Elsevier
Toward the discovery of novel reliable biomarkers, epigenetic alterations have been
repeatedly proposed for the diagnosis and the development of therapeutic strategies against …

[HTML][HTML] Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas

EM Trinidad, A Juan-Ribelles, G Pisano… - Frontiers in …, 2023 - frontiersin.org
Background Liquid biopsy has emerged as a promising, non-invasive diagnostic approach
in oncology because the analysis of circulating tumor DNA (ctDNA) reflects the precise …

[HTML][HTML] Monitoring EGFR-lung cancer evolution: a possible beginning of a “methylation era” in TKI resistance prediction

FP Fabrizio, A Sparaneo, LA Muscarella - Frontiers in Oncology, 2023 - frontiersin.org
The advances in scientific knowledge on biological therapies of the last two decades have
impressively oriented the clinical management of non-small-cell lung cancer (NSCLC) …

Single-stranded pre-methylated 5mC adapters uncover the methylation profile of plasma ultrashort Single-stranded cell-free DNA

JC Cheng, N Swarup, M Morselli… - Nucleic Acids …, 2024 - academic.oup.com
Whole-genome bisulfite sequencing (BS-Seq) measures cytosine methylation changes at
single-base resolution and can be used to profile cell-free DNA (cfDNA). In plasma …

Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems

L Zhang, J Li - Clinical Epigenetics, 2023 - Springer
Background Detecting organ and tissue damage is essential for early diagnosis, treatment
decisions, and monitoring disease progression. Methylation-based assays offer a promising …

Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications

DB Sacdalan, S Ul Haq, BH Lok - Current Oncology, 2024 - mdpi.com
DNA methylation is a fundamental mechanism of epigenetic control in cells and its
dysregulation is strongly implicated in cancer development. Cancers possess an extensively …

Methylated circulating tumor DNA in hepatocellular carcinoma: A comprehensive analysis of biomarker potential and clinical implications

Q Zhu, J Xie, W Mei, C Zeng - Cancer Treatment Reviews, 2024 - Elsevier
The intricate epigenetic landscape of hepatocellular carcinoma (HCC) is profoundly
influenced by alterations in DNA methylation patterns. Understanding these alterations is …